1.1Stand mounted transducer array
A lockable articulated arm supports the transducer head, and a headrest limits neck movement. A spring-loaded mount maintains contact through a layer of acoustic coupling gel.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A lockable articulated arm supports the transducer head, and a headrest limits neck movement. A spring-loaded mount maintains contact through a layer of acoustic coupling gel.
An isolated constant-current driver sends biphasic pulses between two hydrogel electrodes through a conductive path in the tissue. The driver reverses current polarity within each pulse to balance the delivered charge.
A timer triggers a recording window before the first stimulation block and after each subsequent block. The controller derives heart rate variability from beat intervals and averages skin conductance within each window.
The recorder derives beat intervals from the electrocardiogram and measures skin conductance across the finger electrodes. It sends time-stamped measurements over a short-range radio link to the stimulation controller.
The controller holds pulse timing and output level constant during each session while recording physiological data. After the session, it compares response summaries with baseline values and stores the next session's settings within preset limits.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A wearable collar couples its ultrasound array to a layered neck phantom with an embedded hydrophone at the nominal stellate ganglion location. A physiological signal simulator feeds synthetic heartbeat and skin conductance signals into the collar's sensor inputs. The controller adjusts the pulse train in response to those signals, and a bench recorder captures the hydrophone output alongside the simulated inputs and controller commands.
A reflectance photoplethysmography module in an ear clip replaces electrical heartbeat sensing and sends timestamped pulse detections to the collar controller over a wired link. A light emitting diode illuminates the earlobe, and an adjacent photodiode measures changes in reflected light over each pulse. The controller computes pulse rate variability from accepted interbeat intervals and fuses it with skin conductance from the collar electrodes. The controller holds the current stimulation settings when optical signal quality falls below a configured threshold.
An array of piezoelectric ceramic pillars embedded in a polymer matrix replaces an array of solid ceramic elements in the collar. Each composite element has separate electrodes and a drive channel, with a lossy backing layer behind the array and an acoustic matching layer facing the coupling pad. The drive channels apply calibrated timing delays to focus the emitted pulses while the biometric controller adjusts burst timing through the shared pulse generator.
The collar controller maintains a 60-second rolling buffer of heartbeat intervals and a 10-second rolling buffer of skin conductance samples. Every 5 seconds it calculates the root mean square of successive heartbeat interval differences and fits a linear slope to the conductance samples. The controller uses the resulting feature pair to update the requested pulse repetition rate within configured limits. Both buffers must contain a full window of usable data before adjustment begins.
A wired gateway receives timestamped beat markers from a bedside multiparameter monitor and pairs them with skin conductance readings from the collar. The gateway aligns the two streams to a shared clock and forwards them with their signal quality flags to the collar controller. The controller uses valid data from both streams to adjust the ultrasound pulse train and pauses emission when the gateway reports a disconnected sensor or stale data.
A three-axis accelerometer mounted beside the transducer array streams motion samples to the controller on the same clock as the biometric channels. The controller subtracts a low-pass estimate of gravity and flags windows whose remaining acceleration exceeds a configured threshold. It excludes heartbeat intervals and conductance samples from flagged windows and holds the stimulation settings until both channels supply a fresh usable window.
A padded collar carries the transducer array on a sliding carrier with a locking screw. A compliant mount holds the array face against a gel pad as the carrier moves along the collar.
Individual channels drive the piezoelectric elements of the array with short ultrasound bursts. Programmed timing offsets align the emitted waves at the selected focal location.
A light-emitting diode and photodiode in the collar continuously record a peripheral pulse waveform, and the processor estimates heart rate variability from pulse intervals. Two skin-contact electrodes in the same collar measure conductance with a small applied voltage.
A microcontroller computes rolling averages of skin conductance and rolling estimates of heart rate variability. At each update, it compares both measurements with preset ranges and changes the next burst interval by at most one programmed step.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Fourth, a loop or remote suture electrode can be used to place over the stellate ganglion and/or ansa subclavius, or more than one electrode can be targeted along the stellate ganglion and/or ansa subclavius for redundancy and/or diagnostics.A · US 2021/0244951 A1 · ¶ 10
In order to provide a technical means that offers excellent convenience, usability, and safety for stellate ganglion block that can effectively suppress sympathetic overexcitation, this stellate ganglion magnetic stimulation device comprises: a head unit having a magnet for generating magnetism; and a neck unit that is removably worn around a wearer's neck and that presses the head unit against epidermis corresponding to the stellate ganglion so that stimulation by the magnetB · US 2024/0157164 A1 · abstract
For example, it is possible to use an electromagnet as the magnet 3 (that is, to form a dynamic magnetic field). By changing the magnetic field on the body surface by using a coil, a current is generated in the living body non-invasively to stimulate nerves.B · US 2024/0157164 A1 · ¶ 92
As a method or procedure for evaluating the adequacy of the wearing position of the magnet 3, it is possible to use a physiological index reflecting the state of the sympathetic nerves, as typified by the heart rate variability analysis system described later. For example, it is possible to construct a system that senses the above physiological index in a relatively short period of time and displays the sensed physiological index.B · US 2024/0157164 A1 · ¶ 57
The distal or downstream electrode pair forms the sensor-check arm to determine whether delivery was sufficient to affect neural function, and then feeds the gathered information to the primary-sensor arm (with upstream electrodes confirming effect or lack thereof). This constant feedback dose titration can allow much lower outputs of stimulation without the need for a safety margin for paced output and can include two important sequelae of practical value.A · US 2021/0244951 A1 · ¶ 52
An empty cell means only that no passage was reproduced there.
Hypertension, commonly known as high blood pressure, is a long-term condition in which the blood pressure is persistently elevated and can affect 16-37% of the population globally.A · US 2021/0244951 A1 · ¶ 3
For example, this document describes methods and devices for providing stimulation or ablation to the stellate ganglion to modify blood pressure.A · US 2021/0244951 A1 · ¶ 6
However, the stellate ganglion block injection proposed in Patent Document 1 cannot be readily used outside of medical institutions, and there is a risk of side effects and infection due to direct insertion of the needle into the body.B · US 2024/0157164 A1 · ¶ 7
Accordingly, an object of the present invention is to provide a technical means that offers excellent convenience, usability, and safety for stellate ganglion block that can effectively suppress sympathetic overexcitation.B · US 2024/0157164 A1 · ¶ 8
patent.fyi, US 2026/0355543 A1, claim 1, first published 2026-11-19T12:45:34-05:00, https://patent.fyi/US20260355543/, SHA-256 30769c0810183087825b5e1531440bd530556dc28cc0684ed2c3e2c64c636bb7